Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Tumor Immunotherapy01:27

Tumor Immunotherapy

659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Vaccines01:30

Cancer Vaccines

509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
The Tumor Microenvironment02:17

The Tumor Microenvironment

6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Chronic low-dose iron exposure induces GPX4-mediated resistance to ferroptosis in a human chondrocyte cell line.

Cell and tissue research·2026
Same author

Elevated Circulating Follistatin Is Associated With Diabetic Status and Glycemic Dysregulation in Patients With β-Thalassemia Major.

Cell biochemistry and function·2026
Same author

Short-Chain Fatty Acids Modulate Iron Metabolism and Induce Oxidative Stress and Ferroptosis in Breast Cancer Cells.

Journal of biochemical and molecular toxicology·2026
Same author

Estrogen-Induced Hypermethylation Silencing of <i>RPS2</i> and <i>TMEM177</i> Inhibits Energy Metabolism and Reduces the Survival of CRC Cells.

Cells·2026
Same author

Modulation of hepcidin synthesis: the core link in the bi-directional relationship between iron and obesity.

Reviews in endocrine & metabolic disorders·2025
Same author

Cancer-associated fibroblasts in hepatocellular carcinoma: heterogeneity, mechanisms and therapeutic targets.

Hepatology international·2025

関連する実験動画

Updated: Sep 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K

ガンにおけるTIGIT: 作用機構から有望な免疫療法戦略へ

Haozhe Cui1, Mawieh Hamad2, Eyad Elkord3,4

  • 1Department of Biosciences and Bioinformatics & Suzhou Municipal Key Lab of Biomedical Sciences and Translational Immunology, School of Science, Xi'an Jiaotong-Liverpool University, Suzhou, Jiangsu, China.

Cell death & disease
|September 1, 2025
PubMed
まとめ

TIGIT免疫チェックポイントはT細胞とNK細胞の活動を抑制する. 臨床試験における抗TIGIT抗体単体療法の限界のために,新しい組み合わせの治療法と代替アプローチが検討されています.

さらに関連する動画

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

670
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K

関連する実験動画

Last Updated: Sep 9, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
09:04

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

670
Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

6.8K

科学分野:

  • 免疫学
  • 癌 生物学
  • 薬物開発

背景:

  • TIGIT (IgとITIMドメインを持つT細胞免疫受容体) は免疫チェックポイントタンパク質です.
  • 様々なメカニズムでT細胞とNK細胞の細胞毒機能を抑制する.
  • TIGITはPVRのようなタンパク質ファミリーに属し,CD155と相互作用する.

研究 の 目的:

  • TIGITによる免疫抑制のメカニズムを見直す
  • TIGITを標的とした新興の免疫療法戦略について議論する.
  • 現在の臨床試験とTIGITベースの治療法の将来の方向性を概説する.

主な方法:

  • TIGITの機能と治療戦略に関する文献レビュー
  • 抗TIGIT治療の臨床前および臨床試験データの分析
  • モノクローナル抗体以外の代替アプローチの検討

主要な成果:

  • TIGITは,T細胞とNK細胞の活動を抑制することで,抗腫瘍免疫を抑制する.
  • TIGITに対するモノクローナル抗体の単独治療は,限られた臨床効果を示した.
  • 小分子阻害剤や CAR-T細胞のような 組み合わせた治療法や 代替戦略は有望です

結論:

  • TIGITの複雑な抑制メカニズムを理解することは極めて重要です.
  • TIGITを標的とした 組み合わせ免疫療法が 癌治療の有望な道を示しています
  • 現在の限界を克服するために,代替のTIGITターゲティング戦略に関するさらなる研究が必要である.